# Metformin in Patients With PCOS and Predictors of Poor Ovarian Response Ongoing In-vitro Fertilization

> **NCT01208740** · PHASE4 · TERMINATED · sponsor: **University Magna Graecia** · enrollment: 88 (actual)

## Conditions studied

- Infertility
- PCOS
- Prognosis for Poor Response

## Interventions

- **DRUG:** Metformin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01208740
- **Lead sponsor:** University Magna Graecia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-01
- **Primary completion:** 2010-10
- **Final completion:** 2011-03
- **Target enrollment:** 88 (ACTUAL)
- **Why stopped:** Concerns about safety at the first interim analysis
- **Last updated:** 2011-05-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01208740

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01208740, "Metformin in Patients With PCOS and Predictors of Poor Ovarian Response Ongoing In-vitro Fertilization". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01208740. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*